Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
12 | SERPINA3 | serpin family A member 3 | |
28 | ABO | ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | |
290 | ANPEP | alanyl aminopeptidase, membrane | |
671 | BPI | bactericidal permeability increasing protein | |
728 | C5AR1 | complement C5a receptor 1 | |
842 | CASP9 | caspase 9 | |
920 | CD4 | CD4 molecule | |
928 | CD9 | CD9 molecule | |
929 | CD14 | CD14 molecule | |
968 | CD68 | CD68 molecule |
Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
12260 | C1qb | complement component 1, q subcomponent, beta polypeptide | |
12273 | C5ar1 | complement component 5a receptor 1 | |
12371 | Casp9 | caspase 9 | |
12475 | Cd14 | CD14 antigen | |
12504 | Cd4 | CD4 antigen | |
12514 | Cd68 | CD68 antigen | |
12527 | Cd9 | CD9 antigen | |
14178 | Fgf7 | fibroblast growth factor 7 | |
14308 | Fshb | follicle stimulating hormone beta | |
14964 | H2-D1 | histocompatibility 2, D region locus 1 |
Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
24464 | Hp | haptoglobin | |
24770 | Ccl2 | C-C motif chemokine ligand 2 | |
24794 | Serpina3c | serine (or cysteine) proteinase inhibitor, clade A, member 3C | |
24795 | Serpina3n | serpin family A member 3N | |
24835 | Tnf | tumor necrosis factor | |
24932 | Cd4 | Cd4 molecule | |
24936 | Cd9 | CD9 molecule | |
25325 | Il10 | interleukin 10 | |
25329 | Lhb | luteinizing hormone subunit beta | |
25447 | Fshb | follicle stimulating hormone subunit beta |
Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
387303 | gbgt1l4 | globoside alpha-1,3-N-acetylgalactosaminyltransferase 1, like 4 | |
447881 | gbgt1l3 | globoside alpha-1,3-N-acetylgalactosaminyltransferase 1, like 3 | |
492331 | ace2 | angiotensin I converting enzyme 2 | |
563897 | gbgt1l5 | globoside alpha-1,3-N-acetylgalactosaminyltransferase 1, like 5 | |
566487 | gbgt1l2 | globoside alpha-1,3-N-acetylgalactosaminyltransferase 1, like 2 | |
100005565 | gbgt1l8 | globoside alpha-1,3-N-acetylgalactosaminyltransferase 1, like 8 | |
100005704 | gbgt1l9 | globoside alpha-1,3-N-acetylgalactosaminyltransferase 1, like 9 |
Gene ID | Gene Symbol | Description | Source | Organism |
---|---|---|---|---|
373802 | pomc.S | proopiomelanocortin S homeolog | Xenopus laevis (African clawed frog) | |
380532 | pomc.L | proopiomelanocortin L homeolog | Xenopus laevis (African clawed frog) | |
397778 | tgfb1.L | transforming growth factor beta 1 L homeolog | Xenopus laevis (African clawed frog) | |
495825 | abo.3.L | ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase) L homeolog | Xenopus laevis (African clawed frog) | |
549437 | abo.3 | ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase) gene 3 | Xenopus tropicalis (tropical clawed frog) | |
549858 | abo.2 | ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase) gene 2 | Xenopus tropicalis (tropical clawed frog) | |
550054 | abo | ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase) gene 1 | Xenopus tropicalis (tropical clawed frog) | |
100037182 | ace2.S | angiotensin converting enzyme 2 S homeolog | Xenopus laevis (African clawed frog) | |
100497509 | abo.4 | ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase) gene 4 | Xenopus tropicalis (tropical clawed frog) | |
108698211 | abo.2.L | ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase) gene 2 L homeolog | Xenopus laevis (African clawed frog) |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024